<html>
<head>PUBMED IDs for MYO1B</head>
<body bgcolor='#C5F0F2'><h1>MYO1B</h1><a href='https://pubmed.ncbi.nlm.nih.gov/17352388/'>Clinical and molecular characterization of a patient with a 2q31.2-32.3 deletion identified by array-CGH.</a> March 14  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/24743044/'>Novel downstream molecular targets of SIRT1 in melanoma: a quantitative proteomics approach.</a> January 28  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26811410/'>Specific behavioural phenotype and secondary cognitive decline as a result of an 8.6â€‰Mb deletion of 2q32.2q33.1.</a> December 15  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27225591/'>Gene and MicroRNA Expression Are Predictive of Tumor Response in Rectal Adenocarcinoma Patients Treated With Preoperative Chemoradiotherapy.</a> May 27  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28088345/'>Phenotypic characterization of perivascular myoid cell neoplasms, using myosin 1B, a newly identified human pericyte marker.</a> January 16  2017<br></body></html>
